Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:COGT News 30 December 2025 - 14 January 2026

Cogent Biosciences (COGT) stock jumps as FDA filing timeline sharpens — what investors watch next

Cogent Biosciences (COGT) stock jumps as FDA filing timeline sharpens — what investors watch next

Cogent Biosciences shares climbed about 8% Wednesday after the company set a 2026 timetable for U.S. filings of its lead drug, bezuclastinib. Cogent expects FDA acceptance of its first application by the end of February and aims for a possible commercial launch in the second half of 2026. The stock traded at $38.17 midday. The company began the year with about $900 million in cash.
14 January 2026
·
Why Cogent Biosciences stock is down today after its FDA filing for bezuclastinib

Why Cogent Biosciences stock is down today after its FDA filing for bezuclastinib

NEW YORK, December 30, 2025, 14:40 ET — Regular session Shares of Cogent Biosciences, Inc. fell 2.7% to $36.88 on Tuesday after the biotech said it submitted a New Drug Application to the U.S. Food and Drug Administration for its drug candidate bezuclastinib in nonadvanced systemic mastocytosis. Yahoo Finance An NDA is the formal request asking the FDA to review a drug for marketing approval, a key inflection point for development-stage biotechs with no products on the market. U.S. Food and Drug Administration Systemic mastocytosis is a rare disorder marked by abnormal accumulation and activation of mast cells — immune
30 December 2025
··

Stock Market Today

Utilities stocks brace for a rate test next week after XLU lags Dow’s 50,000 rally

Utilities stocks brace for a rate test next week after XLU lags Dow’s 50,000 rally

7 February 2026
New York, Feb 7, 2026, 13:39 EST — Market closed. U.S. utilities stocks closed higher on Friday, but the sector again looked like the slow lane in a fast market. The Utilities Select Sector SPDR ETF (XLU) rose 0.58% to $43.35, while the S&P 500 climbed 1.97% and the Dow gained 2.47% to 50,115.67. (Investing.com) That gap matters now because utilities are dividend-heavy “bond proxies” — stocks investors often treat as income substitutes for bonds. When Treasury yields rise, the competition from safer bond income tends to pinch utility valuations. The next catalyst is the U.S. economic calendar. The Employment
Real estate stocks rise as rate-cut bets return; XLRE ends at $41.99 ahead of payrolls and CPI

Real estate stocks rise as rate-cut bets return; XLRE ends at $41.99 ahead of payrolls and CPI

7 February 2026
U.S. real estate stocks rose Friday, with XLRE up 1.8% to $41.99 and VNQ and IYR each gaining 1.6%. The Dow closed above 50,000 for the first time as the 10-year Treasury yield ended at 4.206%. Bank of America downgraded Public Storage and Extra Space Storage, citing weak housing turnover and high borrowing costs. The delayed January jobs report is set for Feb. 11, with CPI due Feb. 13.
Go toTop